Insider Actions for Horizon Therapeutics PLC
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 01/14/2022 |
Timothy P. Walbert Chairman, President and CEO; Director |
25,000 | Disposition at $90.02 per share. | 2,250,500 |
| 01/14/2022 |
Timothy P. Walbert Chairman, President and CEO; Director |
25,000 | Derivative/Non-derivative trans. at $22.14 per share. | 553,500 |
| 01/06/2022 |
Andy Pasternak EVP and Chief Business Officer |
349 | Disposition at $100.23 per share. | 34,980 |
| 01/06/2022 |
Andy Pasternak EVP and Chief Business Officer |
6,438 | Disposition at $99.85 per share. | 642,834 |
| 01/06/2022 |
Andy Pasternak EVP and Chief Business Officer |
700 | Disposition at $98.33 per share. | 68,831 |
| 01/06/2022 |
Andy Pasternak EVP and Chief Business Officer |
500 | Disposition at $97.3 per share. | 48,650 |
| 01/05/2022 |
Timothy P. Walbert Chairman, President and CEO; Director |
3,636 | Derivative/Non-derivative trans. at $101.84 per share. | 370,290 |
| 01/05/2022 |
Timothy P. Walbert Chairman, President and CEO; Director |
174,906 | Derivative/Non-derivative trans. at $101.84 per share. | 17,812,427 |
| 01/05/2022 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
37,675 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Paul W. Hoelscher EVP, CFO |
50,666 | Derivative/Non-derivative trans. at $101.84 per share. | 5,159,825 |
| 01/05/2022 |
Barry J. Moze EVP, Chief Admin. Officer |
49,841 | Derivative/Non-derivative trans. at $101.84 per share. | 5,075,807 |
| 01/05/2022 |
Michael A. DesJardin EVP, Technical Operations |
41,276 | Derivative/Non-derivative trans. at $101.84 per share. | 4,203,547 |
| 01/05/2022 |
Miles W. McHugh Sr VP & Princ. Acctg Officer |
8,175 | Derivative/Non-derivative trans. at $101.84 per share. | 832,542 |
| 01/05/2022 |
Andy Pasternak EVP and Chief Business Officer |
21,710 | Derivative/Non-derivative trans. at $101.84 per share. | 2,210,946 |
| 01/05/2022 |
Elizabeth H.Z. Thompson EVP, Research & Development |
7,030 | Derivative/Non-derivative trans. at $101.84 per share. | 715,935 |
| 01/05/2022 |
Timothy P. Walbert Chairman, President and CEO; Director |
8,043 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Timothy P. Walbert Chairman, President and CEO; Director |
241,750 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
52,570 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Paul W. Hoelscher EVP, CFO |
66,822 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Barry J. Moze EVP, Chief Admin. Officer |
64,959 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Michael A. DesJardin EVP, Technical Operations |
53,734 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Miles W. McHugh Sr VP & Princ. Acctg Officer |
18,289 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Andy Pasternak EVP and Chief Business Officer |
48,839 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Elizabeth H.Z. Thompson EVP, Research & Development |
13,999 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2022 |
Timothy P. Walbert Chairman, President and CEO; Director |
152,896 | Award at $0 per share. | 0 |
| 01/05/2022 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
32,301 | Award at $0 per share. | 0 |
| 01/05/2022 |
Paul W. Hoelscher EVP, CFO |
47,375 | Award at $0 per share. | 0 |
| 01/05/2022 |
Barry J. Moze EVP, Chief Admin. Officer |
47,375 | Award at $0 per share. | 0 |
| 01/05/2022 |
Michael A. DesJardin EVP, Technical Operations |
32,301 | Award at $0 per share. | 0 |
| 12/31/2021 |
Timothy P. Walbert Chairman, President and CEO; Director |
7,522 | Disposition at $108.55 per share. | 816,513 |
| 12/31/2021 |
Timothy P. Walbert Chairman, President and CEO; Director |
67,478 | Disposition at $108.02 per share. | 7,288,973 |
| 12/31/2021 |
Timothy P. Walbert Chairman, President and CEO; Director |
25,000 | Derivative/Non-derivative trans. at $22.14 per share. | 553,500 |
| 12/28/2021 |
Paul W. Hoelscher EVP, CFO |
8,575 | Disposition at $110 per share. | 943,250 |
| 12/28/2021 |
Paul W. Hoelscher EVP, CFO |
8,575 | Derivative/Non-derivative trans. at $15.96 per share. | 136,857 |
| 12/13/2021 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
50 | Gift at $0 per share. | 0 |
| 12/07/2021 |
Andy Pasternak EVP and Chief Business Officer |
1,525 | Disposition at $100 per share. | 152,500 |
| 12/03/2021 |
Paul W. Hoelscher EVP, CFO |
1,049 | Gift at $0 per share. | 0 |
| 12/01/2021 |
Miles W. McHugh Sr VP & Princ. Acctg Officer |
79,484 | Disposition at $106.62 per share. | 8,474,584 |
| 12/01/2021 |
Miles W. McHugh Sr VP & Princ. Acctg Officer |
79,484 | Derivative/Non-derivative trans. at $22.14 per share. | 1,759,775 |
| 11/30/2021 |
Timothy P. Walbert Chairman, President and CEO; Director |
13,487 | Disposition at $103.54 per share. | 1,396,443 |
| 11/30/2021 |
Timothy P. Walbert Chairman, President and CEO; Director |
15,875 | Disposition at $102.62 per share. | 1,629,092 |
| 11/30/2021 |
Timothy P. Walbert Chairman, President and CEO; Director |
20,638 | Disposition at $101.48 per share. | 2,094,344 |
